Skip to content
  • 6,813 federal solicitations are open right now. How many of them are yours?
  • New solicitations are posted every day. The ones you never saw are the ones you cannot win.
  • Stop checking SAM.gov every morning. Let the contracts that fit your business come to you.
  • Tell Abierto what you sell in one sentence. AI reads every open solicitation for you.
  • Deadlines are short. Hear about a solicitation the day it is posted, not the week it closes.
  • Amendments move deadlines. Watch a solicitation and Abierto tells you when it changes.
  • See which contracts in your field are about to end, and who holds them today.
  • Plans from $39 a month. See your matches before you pay.
See plans
AbiertoGet started
Menu

Award notice, total small business set-aside

Nanovaccine for Eliciting Broadly Neutralizing Antibodies against HIV-1

75N93024C00019

National Institutes of Health, National Institutes of Health Niaid. Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).

127 open like this View on SAM.gov Markdown

Awarded

Neovaxsyn Inc.

$2,000,000.00 on the award notice, June 25, 2024, contract 75N93024C00019

Get the next one like this from National Institutes of Health by email, the day it is posted.Find my opportunities

This one was awarded in 2025

127 like it are open now in research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology)

All 127 open in research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology)

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Neovaxsyn Inc.
UEI
EHMTBALCKFE8
CAGE
7RK00
Vendor location
Ames, IA
Contract
75N93024C00019, definitive contract
Obligated
$2,000,000.00
Actions
2 between June 25, 2024 and June 25, 2026
Competition
Full and Open Competition After Exclusion of Sources, 2 offers received
Set-aside reported
Small Business Set Aside - Total
Described as
Nanovaccine for Eliciting Bnabs Against HIV-1
Match
award number 75N93024C00019 equals the contract number; same awarding office 75N930 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. July 1, 2024

    Award notice

    Awarded to NEOVAXSYN Inc. Ames for $2,000,000. SAM.gov, notice 73b10a8dcc7541e29ed05495fc04fd9a

  2. January 14, 2025

    Award notice

    Awarded to NEOVAXSYN Inc. Ames for $2,000,000. SAM.gov, notice dd394377adbf4116aaf84d47abc943ca

Points of contact